Rchr
J-GLOBAL ID:200901071775663033   Update date: Feb. 01, 2024

TAKASHI KAMIGAKI

カミガキ タカシ | TAKASHI KAMIGAKI
Affiliation and department:
Job title: Lecturer
Homepage URL  (1): https://www.juntendo.ac.jp/graduate/laboratory/labo/next-i/
Research keywords  (6): 再生医療 ,  消化器外科学 ,  細胞療法 ,  免疫療法 ,  腫瘍学 ,  oncology gastrointestinal surgery
Research theme for competitive and other funds  (9):
  • 2023 - 2026 Immunological analysis and POC establishment of comprehensive neoantigen-specific immunotherapy for cold tumor
  • 2019 - 2022 Development of comprehensive cancer immunotherapy using PD-1 positive tumor specific T lymphocytes
  • 2016 - 2019 Elucidation of the mechanism of immune activation and identification of novel target molecules associated with allogeneic reactions
  • 2015 - 2018 Establishment of postoperative adjuvant immunotherapy using peptide pool of tumor antigens in advanced esophageal cancer
  • 2013 - 2016 Development of cancer treatment harnessing NKT cells with a cross-talk of innate and acquired immunity
Show all
Papers (104):
  • Rishu Takimoto, Takashi Kamigaki, Hisao Ito, Masashi Saito, Ken Takizawa, Kenzo Soejima, Hiroyuki Yasuda, Keiko Ohgino, Hideki Terai, Katsuro Tomita, et al. Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG). Cytotherapy. 2023
  • Rishu Takimoto, Takashi Kamigaki, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Shigenori Goto. Efficacy of Adjuvant Immune-cell Therapy Combined With Systemic Therapy for Solid Tumors. Anticancer research. 2022. 42. 8. 4179-4187
  • Rishu Takimoto, Takashi Kamigaki, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Shigenori Goto. Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell Therapy. Anticancer research. 2021. 41. 8. 4133-4141
  • Rishu Takimoto, Takashi Kamigaki, Takuji Gotoda, Toshimi Takahashi, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Shigenori Goto. Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports. Journal of medical case reports. 2021. 15. 1. 191-191
  • Tatsuo Kumai, Eishiro Mizukoshi, Tomomi Hashiba, Hidetoshi Nakagawa, Masaaki Kitahara, Tomoharu Miyashita, Takafumi Mochizuki, Shigenori Goto, Takashi Kamigaki, Rishu Takimoto, et al. Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer. Cytotherapy. 2021. 23. 2. 137-145
more...
MISC (173):
Patents (3):
Lectures and oral presentations  (286):
  • 腫瘍血管傷害型CAR-T細胞医薬の品質・性能規格化に向けた基礎的検討
    (日本薬学会年会要旨集 2019)
  • 大腸癌術後の再発に対して複合的免疫細胞療法(化学療法/免疫細胞療法)を施行した2例
    (日本癌治療学会学術集会抄録集 2017)
  • エレクトロポレーション法を用いた腫瘍血管を標的としたmRNA-engineered T細胞療法の開発
    (日本消化器外科学会総会 2017)
  • mRNAエレクトロポレーション法により作製した腫瘍血管標的化ヒトCAR-T細胞の品質・機能評価
    (日本DDS学会学術集会プログラム予稿集 2017)
  • 腫瘍血管を標的とするmRNA-engineeredヒトCAR-T細胞の性能・品質評価
    (日本がん免疫学会総会プログラム・抄録集 2017)
more...
Professional career (1):
  • 博士(医学)(神戸大学)
Work history (4):
  • 2017/04 - 現在 Juntendo University
  • 2010 - 現在 Kobe University
  • 2006 - 2009 Kobe University
  • 2004 - 2006 Kobe University
Association Membership(s) (9):
日本膵臓学会 ,  日本大腸肛門病学会 ,  日本胃癌学会 ,  日本消化器病学会 ,  日本消化器外科学会 ,  日本外科学会 ,  日本臨床腫瘍学会 ,  日本癌治療学会 ,  日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page